OTC · CIK 0001815903
PTPI Petros Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing Jun 8, 2026.
In brief
Petros Pharmaceuticals, Inc. (PTPI) has 11 SEC Form 4 filings on file from 5 insiders, the latest filed on Jun 8, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Petros Pharmaceuticals, Inc., scored.
Transactions
Every row filed, 11 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Wayne Remell Walker director | AGrant or award Common Stock | +375,000 | $0.00 | $0 | 881,333 | Jun 8, 2026 |
| Jun 5, 2026 | Bruce Bernstein director | AGrant or award Common Stock | +1,875,000 | $0.00 | $0 | 3,762,334 | Jun 5, 2026 |
| Jun 5, 2026 | Fady Boctor See Remarks | AGrant or award Common Stock | +375,000 | $0.00 | $0 | 894,986 | Jun 5, 2026 |
| Jun 5, 2026 | Joshua Silverman director | AGrant or award Common Stock | +4,375,000 | $0.00 | $0 | 8,790,450 | Jun 5, 2026 |
| Jan 2, 2026 | Fady Boctor See Remarks | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 519,986 | Jan 6, 2026 |
| Jan 2, 2026 | Bruce Bernstein director | AGrant or award Common Stock | +1,875,000 | $0.00 | $0 | 1,887,334 | Jan 2, 2026 |
| Jan 2, 2026 | Wayne Remell Walker director | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 506,333 | Jan 2, 2026 |
| Jan 2, 2026 | Joshua Silverman director | AGrant or award Common Stock | +4,375,000 | $0.00 | $0 | 4,415,450 | Jan 2, 2026 |
| Feb 19, 2025 | Mitchell Arnold See Remarks | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 150,000 | Feb 21, 2025 |
| Feb 19, 2025 | Bruce Bernstein director | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 308,346 | Feb 21, 2025 |
| Feb 19, 2025 | Fady Boctor See Remarks | AGrant or award Common Stock | +450,000 | $0.00 | $0 | 499,645 | Feb 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Mitchell ArnoldSee Remarks
- Bruce Bernsteindirector
- Fady BoctorSee Remarks
- Joshua Silvermanchair, officer, director, ceo, president
- Wayne Remell Walkerdirector
Questions about PTPI
Answered from the filings on this page, as of the latest one.
Are insiders buying PTPI?
No. In the last 90 days no insider at Petros Pharmaceuticals, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PTPI on the open market?
No open-market trade has been scored at Petros Pharmaceuticals, Inc.. The latest Form 4 on file was filed on Jun 8, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Petros Pharmaceuticals, Inc.?
5 people have filed a Form 4 at Petros Pharmaceuticals, Inc., among them Mitchell Arnold (See Remarks), Bruce Bernstein (director), Fady Boctor (See Remarks). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.